Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, researchers developed a new microneedle patch delivery system for minoxidil, which enhanced its controlled release and improved hair growth in mice, potentially offering better treatment outcomes for androgenetic alopecia.

In this retrospective chart review, researchers observed that estrogen monotherapy effectively suppressed testosterone levels below 50ng/dL in all transfeminine patients studied, particularly those using injectable formulations, though the small sample size and ongoing data collection limit these findings.

In this retrospective study, among transfeminine patients aged 19-81 receiving gender-affirming estrogen therapy, 100% achieved testosterone suppression without anti-androgens when serum estradiol exceeded 100pg/mL, predominantly using injectable estrogen.

This literature review on androgenetic alopecia highlights its significant impact on patients' mental health and quality of life and discusses various treatment pathways, including topical, systemic, and surgical interventions, while emphasizing the need for continued research to develop effective therapies.

Fractionated laser therapy, especially erbium-glass laser, effectively increases hair thickness in people with hair loss but doesn't increase the number of hairs.

This article reviews evidence-based complementary strategies to enhance hair regrowth after post-COVID-19 telogen effluvium, emphasizing psychological support, patient education, nutrition, and both topical and injectable hair growth stimulators.

This review discusses prevention, diagnosis, and treatment strategies for traction alopecia but presents no new clinical findings; the authors emphasize early intervention to prevent permanent hair loss.

This review discusses exosomal micro RNAs from dermal papilla cells in hair follicle mediation and reports no new clinical results.

This overview discusses the Dermatologic Surgery journal, which provides comprehensive coverage of cosmetic and reconstructive skin surgery and reports no new clinical results.

This abstract introduces the Dermatologic Surgery journal as a leading source of comprehensive and up-to-date information on cosmetic and reconstructive skin surgery and skin cancer. It highlights the journal's wide range of peer-reviewed content, making it essential reading for professionals in dermatology and related fields.

This overview describes the content and scope of the Dermatologic Surgery journal, which includes a wide range of information on cosmetic and reconstructive skin surgeries but reports no new research results.

This review identifies headache, hypertrichosis, and allergy as potential side effects of Minoxidil treatment for hair loss, based on only two studies that met inclusion criteria.

Hormonal contraceptives are effective for teens but require careful consideration of side effects and individual health.

The document concludes that understanding risks, careful patient selection, precise surgery, quick complication management, and good communication can improve cosmetic facial surgery outcomes.

This study found that an injectable hair material showed good biocompatibility in micropigs and effectively promoted dermal thickening, suggesting its potential as a new soft tissue filler.

This conference summary covers advancements in dermatology, including aging skin and acne therapies, but reports no new experimental results.

This study assessed contraceptive use among women in Mukalla city, Yemen, reporting that 78.7% experienced side effects such as hair loss and abnormal bleeding, with oral contraceptive pills being the most common method.

This source discusses the ethical dilemmas and business pressures in cosmetic dermatology, emphasizing the shift toward commercialism and profit-driven practices influenced by social media and market demands, potentially leading to conflicts of interest and professional misconduct.

This article discusses misconceptions surrounding level 7 qualifications in aesthetic training and emphasizes the importance of selecting reputable training providers, without presenting new research results.

This study reported significant improvements in female pattern hair loss through a combination therapy involving spironolactone, minoxidil, and an injectable treatment over 6 to 12 months, with 95-96% patient satisfaction and minimal complications such as slight pain and hair growth in undesirable areas.

This paper discusses the non-curable nature of alopecia and explores various treatments, their side effects, cost, and effectiveness, while also examining how diet, COVID-19, and the COVID-19 vaccine may affect the condition.

Men's facial rejuvenation involves unique challenges and is increasingly popular, with many opting for nonsurgical treatments.

This review discusses nonsurgical techniques for facial masculinization and feminization in transgender patients and reports no new clinical findings, utilizing data from analogous procedures in cisgender individuals.

This review discusses lesser-known concerns in transgender dermatology, including neovaginal issues, neoplastic and autoimmune conditions, and the effects of unapproved injectable substances, but reports no new clinical findings.

This study reviewed research on the psychosocial effects of gender-affirming dermatology treatments in transgender populations, finding mostly positive associations but noting significant limitations and the need for more comprehensive studies to clearly understand these effects.

This article discusses the JCCP's new Premises Standards for aesthetic practitioners, focusing on how these guidelines help ensure patient safety, and reports no new research findings.

This source examines alopecia areata, an autoimmune condition causing patchy hair loss, describing the current reliance on corticosteroid injections despite their severe side effects, and explores Ayurvedic treatments identified as Shaman and Shodhan for managing an equivalent condition called Indralupta.

This study surveyed UK patients who experienced adverse events from Botulinum Toxin for cosmetic purposes, finding 79% reported issues like long-lasting anxiety, and highlighting low awareness of regulatory bodies and reporting structures.

This case report describes the successful use of percutaneous and endovascular embolization with PHIL embolic agent to treat a rare scalp arteriovenous fistula following a hair transplant.

This article reviews emerging therapies for androgenetic alopecia, highlighting advances like androgen-receptor antagonists and improved minoxidil delivery that aim to enhance treatment efficacy and safety.